Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/1989
03/22/1989EP0308147A1 Hyposensitization agent
03/22/1989EP0307904A1 Covered sustained-release forms
03/22/1989EP0307857A1 Stabilization of therapeutically active proteins in pharmaceutical preparations
03/22/1989EP0307827A2 Novel macromolecular complexes, process for producing same and medicinal use of such complexes
03/22/1989EP0307626A1 Process for preparing an anti-oxidant spice extract
03/22/1989EP0307534A2 A heterogeneous multiple-branched cyclodextrin and method for the preparation thereof
03/22/1989EP0307480A1 Process for preparing antibody complex
03/22/1989CN1031801A Stabilised human protein preparations
03/21/1989US4814438 Immunoglobulin conjugates of 2',2'-difluronucleosides
03/21/1989US4814184 Sustained release
03/21/1989US4814182 Controlled release device
03/21/1989US4814173 Catalyst not poisioned by drug
03/21/1989US4814170 Method for immunization against and treatment of infection by ectoparasites and endoparasites
03/21/1989US4814169 Innoculating animals, spleen cells, immunology
03/21/1989US4814161 Drug-containing chlorofluorocarbon aerosol propellent formulations
03/21/1989US4813924 Drugs, haptens, antigens, antibodies
03/21/1989CA1251402A1 Parenteral formulation of dezocine
03/15/1989EP0307097A2 Water-insolubilized cytokines
03/15/1989EP0307083A2 Composition for external use containing an ethoxylated compound
03/15/1989EP0306984A1 Preservative system for ophtalmic formulations
03/15/1989EP0306971A2 Use of milk fat globules as carriers for drugs and as microflotation devices in immunoassays and cell/molecular fractionation
03/15/1989EP0306943A2 Immunconjugates joined by thioether bonds having reduced toxicity and improved selectivity
03/15/1989EP0306824A2 Stabilized human protein preparations
03/15/1989EP0192640B1 Sucralfate suspension
03/14/1989US4812566 Reacting azacycloheptane-2-one with dodecyl halide in the pressence of a quaternary ammonium phase transfer catalyst
03/14/1989US4812557 Stable composition of interleukin-2 and human serum albumin
03/14/1989US4812480 Composition for administration through a body cavity
03/14/1989US4812475 New method of treatment using prostaglandin analogues
03/14/1989US4812457 Prostaglandin derivatives
03/14/1989US4812444 Dehydration of hydrous matter using anhydrous glycosylfructose
03/14/1989US4812316 Polyvinylpyrrolidone binder
03/14/1989US4812312 Liposome-incorporated nystatin
03/09/1989WO1989001790A1 A dressing material comrpising a pharmacological active agent entrapped in liposomes
03/09/1989WO1989001779A1 Molecular decoyants and methods of use thereof
03/09/1989WO1989001773A1 Synovial phospholipases
03/09/1989WO1989001772A1 Ocular cyclosporin composition
03/08/1989EP0306473A1 Pharmaceutical structure with protein-supported agents
03/08/1989EP0306455A1 Cyclodextrin complexes of bis-biguanido hexane compounds
03/08/1989EP0306312A1 Lyophilized pharmaceutical composition of neocarzinostatin derivative
03/08/1989EP0306192A2 Permeation enhancement compositions
03/08/1989EP0305968A2 Compositions against protozoal diseases
03/08/1989EP0305967A2 Conjugates of interferon alpha with immunoglobulins
03/08/1989EP0305918A1 Controlled release delivery coating formulation for bioactive substances
03/08/1989EP0305726A1 Transdermal therapeutic system
03/08/1989EP0305384A1 Water soluble polyvinyl lactam-drug complexes
03/07/1989US4810827 Dehydration of hydrous matter using anhydrous aldohexose
03/07/1989US4810697 Pharmaceutical formula
03/07/1989US4810502 Sustained release dosage form
03/07/1989US4810501 Sustained release pharmaceutical preparations
03/07/1989US4810488 Physically modified beclomethasone dipropionate suitable for use in aerosols
03/07/1989US4810418 Non-drying gel
03/02/1989DE3729826C1 Liniment for preparation for the attachment of an electrode
03/01/1989EP0305026A2 Transdermal drug delivery device with dual permeation enhancers
03/01/1989EP0304424A1 WATER SOLUBLE COMPLEX OF A POLY(VINYLPYRROLIDONE) COPOLYMER AND $g(a)-METHYL-(2-METHYLPROPYL)BENZENE ACETIC ACID
03/01/1989CN1031326A Method for preventing fish and shrimp diseases by using haloplankton as living drug carrier
03/01/1989CN1031325A Topically active compositions of double stranded rnas
03/01/1989CN1031323A Contraceptive implant
02/1989
02/28/1989US4808705 Using glycerol, albumin, and dextran sulfate
02/28/1989US4808617 Heat resistant antibiotic
02/28/1989US4808610 Mometasone furoate anti-inflammatory cream composition using hexylene glycol
02/28/1989US4808585 Solutions of lactic acid salts of piperazinylquinolone- and piperazinyl-azaquinolone-carboxylic acids
02/28/1989US4808583 Solutions of lactic acid salts of piperazinylquinolone- and piperazinyl-azaquinolone-carboxylic acids
02/28/1989US4808577 Boric acid or a salt
02/28/1989US4808415 Adding water to dry cellulose and carboxymethyl starch composition forms gel or cream
02/28/1989US4808414 Amide penetration enhancers for transdermal delivery of systemic agents
02/28/1989US4808411 Antibiotic-polymer compositions
02/28/1989US4808410 Pharmaceutical compositions containing dyclonine HC1 and phenol
02/28/1989US4808353 Process for preparing an artificial biological membrane
02/23/1989WO1989001629A1 Human ovarian tumor-associated antigen specific for monoclonal antibody ov-tl3
02/23/1989WO1989001519A1 Human mannose binding protein
02/23/1989WO1989001476A1 Tetra-aza macrocycles and metal complexes thereof
02/23/1989WO1989001475A1 Tri-aza macrocycles and metal complexes thereof
02/23/1989WO1989001337A1 Methods and compositions for mimicking antigenic determinants
02/23/1989WO1989001335A1 Biospecific polymers
02/22/1989EP0304374A1 Therapeutical preparation containing collagen and imidazole derivatives
02/22/1989EP0304311A1 Complex of polyethylene glycol and tissue plasminogen activator
02/22/1989EP0304183A1 Stabilization of deferoxamine to chelate free ions in physiological fluid
02/22/1989EP0303853A2 Polymer blends having reverse phase morphology for controlled delivery of bioactive agents
02/22/1989EP0303746A1 Stabilization of growth promoting hormones
02/22/1989EP0303713A1 Percutaneous absorption promoter and dermatologic preparation for external use
02/22/1989EP0303669A1 Lactam copolymers
02/22/1989EP0216860A4 Stereoregular polynucleotide-binding polymers.
02/22/1989EP0205530B1 Physically modified beclomethasone dipropionate suitable for use in aerosols
02/21/1989US4806524 Stable erythropoietin preparation and process for formulating the same
02/21/1989US4806494 Monoclonal antibody against ovarian cancer cells (OVB-3)
02/21/1989US4806359 Iburprofen sustained release matrix and process
02/21/1989US4806358 Therapeutic compositions
02/21/1989US4806343 Cryogenic protectant for proteins
02/21/1989CA1250236A1 Gel-form topical antibiotic compositions
02/15/1989EP0303530A1 Polyamide powder made of particles with a "sand rose" structure, and process for its preparation
02/15/1989EP0303516A2 Topically active compositions of double-stranded RNAs
02/15/1989EP0303490A1 Transdermal adminstration using benzyl alcohol
02/15/1989EP0303306A1 Contraceptive implant
02/15/1989EP0303251A2 Injection composition containing modified tPA
02/15/1989CN1031088A Conjugates of superoxide dismutase couples tod high molecular weight polyalkylene glycols
02/14/1989US4804541 Systemic drug delivery
02/14/1989US4804535 Acrylic acid or water soluble salt
02/14/1989CA1250100A1 Pre-s gene coded peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
02/14/1989CA1250090A1 Pharmaceutical composition having an excellent absorption property
02/14/1989CA1249969A1 Pharmaceutical formulations for ceftazidime
1 ... 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 ... 1712